Australia markets closed

Takeda Pharmaceutical Company Limited (TAK)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
16.66-0.09 (-0.52%)
As of 11:45AM EST. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Dec 2020)Next qtr. (Mar 2021)Current year (2021)Next year (2022)
No. of analysts0022
Avg. Estimate000.760.86
Low estimate000.690.76
High estimate000.830.95
Year ago EPSN/A2.990.130.76
Revenue estimateCurrent qtr. (Dec 2020)Next qtr. (Mar 2021)Current year (2021)Next year (2022)
No. of analysts1122
Avg. Estimate7.69M7.34M30.3M30.27M
Low estimate7.69M7.34M30.25M29.35M
High estimate7.69M7.34M30.34M31.19M
Year ago sales793.6M7.19M30.68M30.3M
Sales growth (year/est)-99.00%2.00%-1.20%-0.10%
Earnings historyInvalid Date30/12/201929/06/202029/09/2020
Est. EPSN/A750.990.99
Actual EPSN/A2.990.250.01
DifferenceN/A-72.01-0.74-0.98
Surprise %N/A-96.00%-74.70%-99.00%
EPS trendCurrent qtr. (Dec 2020)Next qtr. (Mar 2021)Current year (2021)Next year (2022)
Current estimate000.760.86
7 days ago1.041.060.760.85
30 days ago1.041.060.690.86
60 days ago1.041.060.690.86
90 days ago1.041.060.70.97
EPS revisionsCurrent qtr. (Dec 2020)Next qtr. (Mar 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesTAKIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year484.60%N/AN/AN/A
Next year13.20%N/AN/AN/A
Next 5 years (per annum)0.58%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A